Inflammatory activity and vitamin D levels in an MS population treated with rituximab
{{output}}
Background: Most multiple sclerosis patients on disease-modifying treatment at Umeå University Hospital are treated with rituximab and the prevalence of vitamin D supplementation has increased over time. Follow-up studies of the... ...
